Combined antiretroviral and antituberculosis drug resistance following incarceration. S Afr J HIV Med, 14(3): 135-137 (2013).

Publication Latest Publications

Title: Combined antiretroviral and antituberculosis drug resistance following incarceration
Authors: Stott KE, de Oliveira T, Lessells RJ.
Journal: S Afr J HIV Med,14(3):135-137 (2013)
Number of citations (Google Scholar): 3

Abstract

We describe a case of HIV/tuberculosis (TB) co-infection from KwaZulu-Natal, South Africa, characterised by drug resistance in both pathogens. The development of drug resistance was linked temporally to two periods of incarceration. This highlights the urgent need for improved integration of HIV/TB control strategies within prison health systems and within the broader public health framework.

Download: Full text paper

Citation: Stott KE, de Oliveira T, Lessells RJ. Combined antiretroviral and antituberculosis drug resistance following incarceration S Afr J HIV Med,14(3):135-137 (2013).


High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients
Journal: Clinical Infectious Diseases (2017)

Virological Outcomes of Second-line Protease Inhibitor?Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis
Journal: Clinical Infectious Diseases (2017)

CD4+ T-cell count may not be a useful strategy to monitor antiretroviral therapy response in HTLV-1/HIV co-infected patients
Journal: Current HIV Research (2017)
All publications...


Page design updated by Tulio de Oliveira, 2013